![]() |
市场调查报告书
商品编码
1892808
眼科缝合线市场机会、成长驱动因素、产业趋势分析及预测(2026-2035年)Ophthalmic Sutures Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
2025 年全球眼科缝合线市场价值为 11 亿美元,预计到 2035 年将以 4.3% 的复合年增长率增长至 18 亿美元。

眼科手术数量的增加、人口老化、技术创新、眼部疾病盛行率上升以及优质医疗保健服务的普及,共同推动了市场扩张。眼科缝合线为医院、专科眼科诊所和门诊手术中心提供至关重要的手术解决方案,可改善患者预后,实现精准的伤口管理,并提高白内障、角膜、青光眼和视网膜手术的手术效率。这些缝合线,包括先进的可吸收和不可吸收缝合线,经过精心设计,具有优异的操作性能、最小的组织损伤和可靠的术后癒合,使眼科医生能够更精确、更安全地进行精细手术。显微外科技术的进步以及门诊和日间眼科手术的日益普及,增加了对能够减少发炎、加速癒合并提供可预测恢復效果的缝合线的需求。新兴经济体医疗基础设施的扩建和支出的成长也提高了患者接受矫正性眼科手术的机会,从而支撑了市场的持续成长。
| 市场范围 | |
|---|---|
| 起始年份 | 2025 |
| 预测年份 | 2026-2035 |
| 起始值 | 11亿美元 |
| 预测值 | 18亿美元 |
| 复合年增长率 | 4.3% |
到2025年,合成缝合线市占率预计将达到68.8%,这主要得益于其高拉伸强度、可预测的吸收性和广泛的临床应用。合成缝合线由聚乳酸-羟基乙酸共聚物、聚乙醇酸和聚二氧杂环己酮等材料製成,具有组织反应性低、感染或发炎风险小等优点,因此非常适合用于精细的眼科手术。
由于其可生物降解性和优异的抗拉强度,PGA(聚乙醇酸)缝合线预计在2025年将占据34.5%的市场份额,价值达6.07亿美元。 PGA缝合线可在体内逐渐降解,无需取出,从而减轻患者不适,减少復诊次数,尤其有利于儿科和老年患者。
2025年,北美眼科缝合线市占率预计将达到38.1%,这主要得益于先进的医疗基础设施、高昂的医疗支出以及眼部疾病盛行率的不断上升。该地区拥有庞大的医院、门诊手术中心和专科眼科诊所网络,进行大量的白内障、青光眼和视网膜手术,从而确保了对眼科缝合线的持续需求。
The Global Ophthalmic Sutures Market was valued at USD 1.1 billion in 2025 and is estimated to grow at a CAGR of 4.3% to reach USD 1.8 billion by 2035.

Market expansion is driven by the rising number of ophthalmic surgeries, an aging population, technological innovations, and increased prevalence of eye disorders, alongside broader access to quality healthcare. Ophthalmic sutures provide crucial surgical solutions to hospitals, specialty eye clinics, and ambulatory surgical centers, enhancing patient outcomes, precise wound management, and surgical efficiency in cataract, corneal, glaucoma, and retinal procedures. These sutures, including advanced absorbable and non-absorbable options, are engineered for superior handling, minimal tissue trauma, and reliable postoperative healing, enabling ophthalmologists to perform delicate surgeries with greater precision and safety. Advancements in microsurgical techniques and the growing trend toward outpatient and ambulatory ophthalmic procedures have increased demand for sutures that reduce inflammation, accelerate healing, and provide predictable recovery outcomes. Expanding healthcare infrastructure and rising expenditure in emerging economies are also improving patient access to corrective eye surgeries, supporting consistent market growth.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $1.1 Billion |
| Forecast Value | $1.8 Billion |
| CAGR | 4.3% |
The synthetic segment held a 68.8% share in 2025, driven by high tensile strength, predictable absorption, and widespread clinical adoption. Synthetic sutures, composed of materials like polyglactin, polyglycolic acid, and polydioxanone, offer reduced tissue reactivity and minimal risk of infection or inflammation, making them highly suitable for delicate eye surgeries.
The PGA segment held a 34.5% share in 2025, valued at USD 607 million, due to its biodegradable properties and excellent tensile strength. PGA sutures degrade gradually in the body, eliminating the need for removal, reducing patient discomfort, and minimizing follow-up visits, particularly benefiting pediatric and geriatric patients.
North America Ophthalmic Sutures Market held a 38.1% share in 2025, supported by advanced healthcare infrastructure, high healthcare expenditure, and growing prevalence of eye disorders. The region's extensive network of hospitals, ambulatory surgical centers, and specialty eye clinics performing a high volume of cataract, glaucoma, and retinal procedures ensures sustained demand for ophthalmic sutures.
Key players in the Global Ophthalmic Sutures Market include Teleflex Incorporated, Assut Medical, Aurolab, Ethicon, Alcon, Corza Medical, Accutome, Mani, DemeTECH, FCI Ophthalmics, Geuder AG, Medtronic, B Braun, and Unilene. Companies in the Ophthalmic Sutures Market are strengthening their position through continuous product innovation, developing sutures with improved handling, biodegradability, and tensile strength. Strategic partnerships with hospitals, clinics, and distributors enable wider reach and faster adoption of new solutions. Expanding global footprints and entering emerging markets allow manufacturers to capture rising demand in underserved regions. Investment in R&D, clinical training programs, and after-sales support enhances brand loyalty, while regulatory compliance and quality certifications build trust among healthcare providers. Marketing initiatives, educational outreach, and digital engagement strategies further solidify their market presence and competitiveness.